FB Rice’s Post

We are excited to share that Ian Rourke, Jenny Petering, and Madeleine Kelly have been included in the 2025 edition of IAM Strategy 300 Global Leaders! This prestigious accolade celebrates individuals making a significant impact in IP strategy and innovation: - Ian Rourke, partner in our biotechnology team, is a leading expert in biotechnology. With a PhD in molecular neuroendocrinology and extensive experience in both scientific research and patent law, Ian excels in the drafting and prosecution of global patent applications. - Jenny Petering, Of Counsel in the biotechnology team, manages extensive IP portfolios for clients at the forefront of biological advancements, including universities, hospitals, and global corporates. A recognised leader in the Australian technological sciences sector, she is actively involved in industry groups and mentoring programs. - Madeleine Kelly, partner in the engineering and computing team, is an expert in IP strategy, multi-jurisdictional prosecution, and portfolio management. With experience as a European and Irish patent and designs attorney, she brings a global perspective, particularly in computer-implemented inventions. Congratulations to Ian, Jenny, and Madeleine on this outstanding achievement! We thank our clients and partners for their support and IAM for this recognition. #IAMStrategy300 #GlobalLeaders2025 #IPStrategy #Innovation

  • graphical user interface, website
Dr Marguerite Evans-Galea AM

Executive leader | Non-Executive Director | Ecosystem builder collaborating for impact | Science | Strategy | Advocacy | Career coaching | Inclusion and allyship | Changemaker | Keynote and MC

2w

Congrats Jenny, Ian and Madeleine! Great news.

Like
Reply

To view or add a comment, sign in

Explore topics